Related Experiment Video

Updated: Jun 6, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Diagnosis and treatment of heart disease: are women different from men?

Borejda Xhyheri1, Raffaele Bugiardini

  • 1Department of Internal Medicine, University of Bologna, Italy.

Progress in Cardiovascular Diseases
|December 7, 2010
PubMed

Insights

Sex differences impact heart disease treatment effectiveness. While some interventions like thrombolytic therapy and percutaneous coronary intervention show similar outcomes, post-discharge medications like statins and ACE inhibitors yield varied benefits for men and women.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Women's Health

Background:

  • Key questions persist regarding the optimal diagnosis, prevention, and treatment of heart disease specifically in women.
  • Existing research highlights potential sex-based differences in treatment efficacy and outcomes for cardiovascular diseases.

Purpose of the Study:

  • To review current knowledge on sex differences in the diagnosis and treatment of ischemic heart disease.
  • To identify gaps in data and guide future research directions in this field.

Main Methods:

  • Literature review of existing studies on sex differences in cardiovascular disease treatment.
  • Analysis of data comparing treatment effectiveness in men versus women for various cardiac interventions and medications.

Main Results:

  • Thrombolytic therapy and percutaneous coronary intervention for acute coronary syndromes demonstrate similar effectiveness in men and women.
  • Post-discharge medical treatments show differential benefits: aspirin's preventive role in women is unproven, statins and ACE inhibitors have varied effects, and beta-blockers may offer greater survival benefits in women.

Conclusions:

  • Significant sex differences exist in the response to and benefits from cardiovascular medications after hospital discharge.
  • Further research is crucial to address data shortcomings and optimize heart disease management strategies tailored to sex-specific needs.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...